Prescription Medications Updated During May 2020, From Oldest to Newest

Page 1 of 192 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

Quetiapine Fumarate

Quetiapine fumarate extended-release tablet is an atypical antipsychotic indicated for the treatment of: Schizophrenia (1.1) Bipolar I disorder, manic or mixed episodes (1.2) …

Lupin Pharmaceuticals, Inc.1 May 2020

Baclofen

Baclofen tablets USP are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant…

Lannett Company, Inc.1 May 2020

Ramipril

Ramipril capsules are an angiotensin converting enzyme (ACE) inhibitor indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of…

Lupin Pharmaceuticals, Inc.1 May 2020

Buspirone Hydrochloride

Buspirone hydrochloride tablets USP are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the…

Oxford Pharmaceuticals, LLC1 May 2020

Armodafinil

Armodafinil tablets are indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA), narcolepsy, or shift work disorder…

Lupin Pharmaceuticals, Inc.1 May 2020

Page 1 of 192 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

FDA Medwatch

Marksans Pharma Limited Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg, Due to the Detection of N-Nitrosodimethylamine (NDMA)
Thu, 04 Jun 2020. Marksans Pharma Limited, India is voluntarily recalling Metformin Hydrochloride Extended-Release Tablets, USP 500mg, lot # XP9004, to the consumer level. FDA analysis has found the product to contain N-Nitrosodimethylamine (NDMA) levels in excess of…
Apotex Corp. Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets 500mg Due to the Detection of N-nitrosodimethylamine (NDMA)
Thu, 04 Jun 2020. Apotex Corp is voluntarily recalling all lots of Metformin Hydrochloride Extended-Release Tablets, USP 500mg within expiry to retail level. Apotex was notified by the U.S. Food and Drug Administration (US FDA) that one lot of Metformin Hydrochloride…

RxDrugLabels

Medication Sections

Medication Information by RSS

About

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.